To investigate a possible impact of the risk variants on gene expression, levels of ESR1, progesterone receptor (PGR) and HER2 (ERBB2) mRNAs were assessed in 1,234 frozen tumour samples (see Materials and Methods). This evidence concerns the gene ERBB2 and neoplasm.